| Barriers and strategies in guideline implementation—a scoping review F Fischer, K Lange, K Klose, W Greiner, A Kraemer Healthcare 4 (3), 36, 2016 | 589 | 2016 |
| Development of the EQ-5D-Y: a child-friendly version of the EQ-5D N Wille, X Badia, G Bonsel, K Burström, G Cavrini, N Devlin, AC Egmar, ... Quality of life research 19 (6), 875-886, 2010 | 582 | 2010 |
| A single European currency for EQ-5D health states W Greiner, T Weijnen, M Nieuwenhuizen, S Oppe, X Badia, J Busschbach, ... The European Journal of Health Economics, formerly: HEPAC 4 (3), 222-231, 2003 | 477 | 2003 |
| Validating the EQ-5D with time trade off for the German population W Greiner, C Claes, JJV Busschbach, JM Graf von der Schulenburg The European journal of health economics 6 (2), 124-130, 2005 | 407 | 2005 |
| Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study U Ravens-Sieberer, N Wille, X Badia, G Bonsel, K Burström, G Cavrini, ... Quality of life research 19 (6), 887-897, 2010 | 357 | 2010 |
| Sozialkapital: Grundlagen von Gesundheit und Unternehmenserfolg B Badura, W Greiner, P Rixgens, M Ueberle, M Behr Springer-Verlag, 2013 | 337 | 2013 |
| Die deutsche version des EuroQol-Fragebogens JM Graf, C Claes, W Greiner, A Uber Zeitschrift für Gesundheitswissenschaften= Journal of public health 6 (1), 3-20, 1998 | 176 | 1998 |
| German value set for the EQ-5D-5L K Ludwig, J Graf von der Schulenburg, W Greiner Pharmacoeconomics 36 (6), 663-674, 2018 | 175 | 2018 |
| Effects of an Internet intervention (Deprexis) on severe depression symptoms: randomized controlled trial B Meyer, J Bierbrodt, J Schröder, T Berger, CG Beevers, M Weiss, ... Internet Interventions 2 (1), 48-59, 2015 | 159 | 2015 |
| German recommendations on health economic evaluation: third and updated version of the Hanover Consensus JM Graf von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, ... Value in health 11 (4), 539-544, 2008 | 144 | 2008 |
| Dacron® vs. PTFE as bypass materials in peripheral vascular surgery–systematic review and meta-analysis S Roll, J Müller-Nordhorn, T Keil, H Scholz, D Eidt, W Greiner, SN Willich BMC surgery 8 (1), 1-8, 2008 | 143 | 2008 |
| Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation-dritte und aktualisierte Fassung des Hannoveraner Konsens JMG von der Schulenburg, W Greiner, F Jost, N Klusen, M Kubin, R Leidl, ... Gesundheitsökonomie & Qualitätsmanagement 12 (05), 285-290, 2007 | 136 | 2007 |
| Gesundheitsökonomik JM Von der Schulenburg, W Greiner Mohr Siebeck, 2007 | 130 | 2007 |
| Effects of a psychological internet intervention in the treatment of mild to moderate depressive symptoms: results of the EVIDENT study, a randomized controlled trial JP Klein, T Berger, J Schröder, C Späth, B Meyer, F Caspar, W Lutz, ... Psychotherapy and psychosomatics 85 (4), 218-228, 2016 | 128 | 2016 |
| Calculation of standardised unit costs from a societal perspective for health economic evaluation JO Bock, C Brettschneider, H Seidl, D Bowles, R Holle, W Greiner, ... Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2014 | 119 | 2014 |
| Cost of care and clinical condition in paediatric cystic fibrosis patients U Baumann, C Stocklossa, W Greiner, JMG von der Schulenburg, ... Journal of Cystic Fibrosis 2 (2), 84-90, 2003 | 100 | 2003 |
| Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ... Pharmacoeconomics 34 (3), 227-244, 2016 | 98 | 2016 |
| Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications J Witte, K Mehlis, B Surmann, R Lingnau, O Damm, W Greiner, ... Annals of Oncology 30 (7), 1061-1070, 2019 | 90 | 2019 |
| Cataract surgery and the development or progression of age-related macular degeneration: a systematic review A Bockelbrink, S Roll, K Ruether, A Rasch, W Greiner, SN Willich Survey of ophthalmology 53 (4), 359-367, 2008 | 88 | 2008 |
| Die Berechnung von Kosten und Nutzen W Greiner Gesundheitsökonomische Evaluationen, 49-63, 2008 | 87* | 2008 |
